Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced this week the granting of inducement awards of Restricted Stock Units (RSUs) totaling 4,500 shares of the Company’s common stock to three …
Neuronetics Announces Inducement Awards for New Team Members Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) revealed a significant development in mental healthcare, announcing that Evernorth Health Services, a subsidiary of The Cigna Group, has expanded its coverage of NeuroStar® …
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has updated its financial results for the fourth quarter and full-year ending December 31, 2024, reflecting revisions related to its acquisition of Greenbrook TMS …
Neuronetics Revises Financial Results for Q4 and Full Year 2024 Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has released its 2024 financial results, detailing significant operational progress and strategic milestones, including the acquisition of Greenbrook TMS, FDA clearance for adolescent …
Neuronetics Reports 2024 Financial Results and Strategic Advances Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the issuance of inducement awards in the form of Restricted Stock Units (RSUs) to three recently hired non-executive employees. These awards, …
Neuronetics Grants Inducement Awards to New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced the issuance of Restricted Stock Units (RSUs) as part of inducement awards granted to two newly hired non-executive employees. The awards cover …
Neuronetics Announces Stock Awards to New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) today announced the pricing of its underwritten public offering of 8,000,000 shares of common stock at $2.25 per share. The offering is expected …
Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has shared its preliminary fourth quarter and full-year revenue figures for 2024, alongside robust guidance and strategic priorities for 2025. The report highlights …
Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has granted performance restricted stock units (PRSUs) to Bill Leonard as part of an inducement award tied to his employment with the company. The …
Neuronetics Awards Stock Units to New Employee Bill Leonard Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the issuance of inducement awards in the form of Restricted Stock Units (RSUs) to seven newly appointed non-executive employees. This strategic …
Neuronetics Grants Inducement Awards to New Employees Read More